Retavase (reteplase), a thrombolytic to restore blood flow after an acute MI
Boehringer Mannheim just started marketing Retavase (reteplase), a thrombolytic to restore blood flow after an acute MI.
Retavase is a derivative of tissue plasminogen activator (tPA).
It restores blood flow within 90 minutes in more patients than tPA (Activase, alteplase).
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote